The abnormal expression of RMI2 is negatively correlated with immune cells and stromal cells in most types of cancer, and it is closely related to B cells, CD4 T cells, CD8 T cells, T cells follicular helper and other TILs and a variety of immune-related genes (ICP, MMRs, m6A). This evidence concerns the gene CD8A and cancer.